The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans

The Journal of Clinical Investigation
M RodenG I Shulman

Abstract

To determine the respective roles of insulin and glucagon for hepatic glycogen synthesis and turnover, hyperglycemic clamps were performed with somatostatin [0.1 micrograms/(kg.min)] in healthy young men under conditions of: (I) basal fasting) portal vein insulinemia-hypoglucagonemia, (II) basal portal vein insulinemia-basal glucagonemia, and (III) basal peripheral insulinemia-hypoglucagonemia. Synthetic rates, pathway (direct versus indirect) contributions, and percent turnover of hepatic glycogen were assessed by in vivo 13C nuclear magnetic resonance spectroscopy during [1-13C]glucose infusion followed by a natural abundance glucose chase in conjunction with acetaminophen to noninvasively sample the hepatic UDP-glucose pool. In the presence of hyperglycemia (10.4 +/- 0.1 mM) and basal portal vein insulinemia (192 +/- 6 pM), suppression of glucagon secretion (plasma glucagon, I:31 +/- 4, II: 63 +/- 8 pg/ml) doubled the hepatic accumulation of glycogen (Vsyn) compared with conditions of basal glucagonemia [I: 0.40 +/- 0.06, II: 0.19 +/- 0.03 mumol/(liter.min): P < 0.0025]. Glycogen turnover was markedly reduced (I: 19 +/- 7%, II: 69 +/- 12%; P < 0.005), so that net rate of glycogen synthesis increased approximately fivefold (P...Continue Reading

References

Jan 1, 1976·Annual Review of Biochemistry·H G Hers
Jan 1, 1979·The Journal of Clinical Endocrinology and Metabolism·J E LiljenquistD Rabinowitz
Aug 1, 1978·The Journal of Clinical Investigation·G I ShulmanA D Cherrington
Oct 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·J KatzP A Wals
Jun 1, 1975·The Journal of Clinical Investigation·D L HorwitzA H Rubenstein
Oct 13, 1975·JAMA : the Journal of the American Medical Association·J E GerichP H Forsham
Mar 1, 1992·Diabetes Care·D K Granner, R M O'Brien
Aug 1, 1991·The Journal of Clinical Investigation·M C MooreG I Shulman
Jan 1, 1989·The Journal of Clinical Endocrinology and Metabolism·L D GrossmanB Zinman
Jan 1, 1986·Scandinavian Journal of Gastroenterology. Supplement·G PleweJ Beyer
Feb 1, 1974·Scandinavian Journal of Clinical and Laboratory Investigation·L H Nilsson, E Hultman
Feb 1, 1984·The Journal of Clinical Endocrinology and Metabolism·J B JaspanE Rayfield
Jun 1, 1980·The Journal of Clinical Investigation·O G KoltermanJ M Olefsky
Nov 1, 1993·The Journal of Clinical Investigation·S DinneenR Rizza

❮ Previous
Next ❯

Citations

Nov 11, 2008·Wiener medizinische Wochenschrift·Michael Roden
Mar 1, 2009·Journal of Cardiovascular Translational Research·Arthur H L From, Kamil Ugurbil
Jan 24, 2002·Journal of Hepatology·Corinne LangLukas Krähenbühl
Aug 26, 2000·Current Opinion in Chemical Biology·B B Zhang, D E Moller
Sep 10, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·Michael Roden, Elisabeth Bernroider
Sep 13, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·K MatykaD B Dunger
Jul 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Varman T SamuelGerald I Shulman
Feb 6, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Saskia KleyDarin E Olson
Apr 13, 2007·Physiological Reviews·David B SavageGerald I Shulman
Oct 15, 1996·The Journal of Clinical Investigation·G VelhoG I Shulman
Aug 15, 1997·The Journal of Clinical Investigation·G PerseghinL Luzi
Apr 29, 1998·The Journal of Clinical Investigation·K F PetersenG I Shulman
Jan 5, 2012·The Journal of Clinical Investigation·Roger H Unger, Alan D Cherrington
Mar 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·W H MartinJ L Treadway
Oct 15, 2011·Cellular and Molecular Life Sciences : CMLS·Akhlaq A FarooquiVincenza Frisardi
Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M NemeczM Roden
Dec 1, 2015·Diabetes Technology & Therapeutics·Ananda Basu, Rita Basu
Jan 28, 2012·Expert Opinion on Therapeutic Targets·Laia SalvadóManuel Vázquez-Carrera
May 28, 2003·Vision Research·Guido T DornerLeopold Schmetterer
Dec 22, 2011·Diabetes·Ya SuRoger Gutiérrez-Juárez
May 13, 2011·Diabetes·Michaela KacerovskyMichael Roden
Nov 25, 2004·Diabetes·Martin KrssakMichael Roden
May 11, 2016·Cell Reports·Adam R KonopkaK Sreekumaran Nair

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Hepatology Research : the Official Journal of the Japan Society of Hepatology
Satoko TakeuchiSumio Watanabe
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme
K KawanakaS Katsuta
Biochimica Et Biophysica Acta
R M Caprioli, W E Seifert
Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie
J LindfeldtT Holmin
© 2021 Meta ULC. All rights reserved